Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Substance-induced anxiety disorder

Substance-Induced Anxiety Disorder. Numerous medicines and drugs of abuse can produce panic attacks. Panic attacks can be triggered by central nervous system stimulants such as cocaine, methamphetamine, caffeine, over-the-counter herbal stimulants such as ephedra, or any of the medications commonly used to treat narcolepsy and ADHD, including psychostimulants and modafinil. Thyroid supplementation with thyroxine (Synthroid) or triiodothyronine (Cytomel) can rarely produce panic attacks. Abrupt withdrawal from central nervous system depressants such as alcohol, barbiturates, and benzodiazepines can cause panic attacks as well. This can be especially problematic with short-acting benzodiazepines such as alprazolam (Xanax), which is an effective treatment for panic disorder but which has been associated with between dose withdrawal symptoms. [Pg.140]

Substance-induced anxiety disorder 300.00 Anxiety disorder not otherwise specified... [Pg.408]

Substance-induced anxiety disorder, e.g. due to alcohol, opiate or sedative abuse. [Pg.291]

Substance-induced delirium Substance-induced psychotic disorder Substance-induced mood disorder Substance-induced persisting amnestic disorder Substance-induced anxiety disorder... [Pg.6]

Mental retardation Substance-induced anxiety disorder ... [Pg.130]

DSM-IV-TR (American Psychiatric Association 2000) recognizes inhalant-, anesthetic-, and solvent-related disorders (Table 13-8). Anesthetics are associated with substance-induced anxiety disorder. Inhalant-related disorders include intoxication, delirium, persisting dementia, psychotic disorders with delusions or hallucinations, mood or anxiety disorders, and disorders not otherwise specified. Diagnosis depends on history or laboratory studies described earlier in this chapter. Physical signs such as deposits from inhalants around the mouth or nose or on hands and clothing may indicate recent use (Westermeyer 1987). Nasal membranes may be inflamed (Wester-meyer 1987). [Pg.205]

Most inhalants or volatile substances are solvents, but the DSM-IV-TR text attributes only five of the eight disorders associated with inhalants to solvents substance-induced psychotic disorder, anxiety disorder, delirium, persisting amnestic disorder, and symptoms of dementia. The association of solvents with dementia is more controversial than their association with mood disorders, but DSM-IV-TR does not recognize mood disorder resulting from solvent exposure. These inconsistencies probably reflect incomplete fidelity between the literature and the psychiatric nosology rather than current opinion. [Pg.205]

Glassification of Substance-Related Disorders. The DSM-IV classification system (1) divides substance-related disorders into two categories (/) substance use disorders, ie, abuse and dependence and (2) substance-induced disorders, intoxication, withdrawal, delirium, persisting dementia, persisting amnestic disorder, psychotic disorder, mood disorder, anxiety disorder, sexual dysfunction, and sleep disorder. The different classes of substances addressed herein are alcohol, amphetamines, caffeine, caimabis, cocaine, hallucinogens, inhalants, nicotine, opioids, phencyclidine, sedatives, hypnotics or anxiolytics, polysubstance, and others. On the basis of their significant socioeconomic impact, alcohol, nicotine, cocaine, and opioids have been selected for discussion herein. [Pg.237]

Primary care physicians are critical to the successful identification of GAD. Characterized by often-vague physical complaints, GAD must be distinguished from medical illnesses and other psychiatric disorders, though the high rate of comorbidity requires that a thorough evaluation for GAD be completed even when another disorder has been identified. GAD warrants particular consideration for those patients with nonspecific physical complaints who nevertheless have an urgent need for relief that has resulted in repeated office visits. The differential diagnosis for GAD includes other anxiety disorders, depression, and a variety of medical conditions and substance-induced syndromes. [Pg.146]

Once chronic insomnia has developed, it hardly ever spontaneously resolves without treatment or intervention. The toll of chronic insomnia can be very high and the frustration it produces may precipitate a clinical depression or an anxiety disorder. Insomnia is also associated with decreased productivity in the workplace and more frequent use of medical services. Einally, substance abuse problems may result from the inappropriate use of alcohol or sedatives to induce sleep or caffeine and other stimulants to maintain alertness during the day. [Pg.262]

The sleep disorders are categorized into primary disorders (i.e., dyssomnias and parasomnias), those related to another mental disorder, those related to a general medical disorder, and those that are substance induced. Like anxiety, disturbances of sleep affect nearly all of us at one time or another. Also like... [Pg.226]

Anxiety disorders (generalized anxiety disorder, obsessive-compulsive disorder, or panic disorder) Substance abuse (alcohol or sedative-hypnotic withdrawal) Pharmacologically induced Anticonvulsants Central adrenergic blockers Diuretics... [Pg.1323]


See other pages where Substance-induced anxiety disorder is mentioned: [Pg.396]    [Pg.147]    [Pg.180]    [Pg.85]    [Pg.90]    [Pg.165]    [Pg.396]    [Pg.147]    [Pg.180]    [Pg.85]    [Pg.90]    [Pg.165]    [Pg.121]    [Pg.104]    [Pg.285]    [Pg.65]    [Pg.355]    [Pg.343]    [Pg.23]    [Pg.119]    [Pg.165]    [Pg.1177]    [Pg.1260]    [Pg.34]    [Pg.120]    [Pg.434]   
See also in sourсe #XX -- [ Pg.140 , Pg.147 ]




SEARCH



Anxiety disorders

Anxiety substance

Anxiety substance induced

Substance-induced

© 2024 chempedia.info